Research Highlight | Published:

ARRHYTHMIAS

Gene therapy to inhibit CaMKII in CPVT

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original article

    1. Bezzerides, V. J. et al. Gene therapy for catecholaminergic polymorphic ventricular tachycardia by inhibition of Ca2+/calmodulin-dependent kinase II. Circulation https://doi.org/10.1161/CIRCULATIONAHA.118.038514 (2019)

    Further reading

    1. Bongianino, R. & Priori, S. G. Gene therapy to treat cardiac arrhythmias. Nat. Rev. Cardiol. 12, 531–546 (2015)

    Download references

    Author information

    Correspondence to Gregory B. Lim.

    Rights and permissions

    Reprints and Permissions

    About this article